Complementing DepMap: Expanding the toolkit for oncology target discovery and de-risking
The Cancer Dependency Map and the Open Targets Platform provide a strong foundation for discovering new therapeutic targets for ground-breaking precision medicines based on the genetic mutations that drive disease. Now, new tools are building on this foundation to help innovative companies identify hidden clinical positioning opportunities in competitive spaces.
